WHWei-Qing Han

Wei-Qing Han

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Wei-Qing Han has a total of 110 co-authors. Here are the top co-authors by number of shared publications:

  • Pin-Lan Li

    Virginia Commonwealth Univ, Richmond, VA

    8 shared publications
  • Min Xia

    Department of Pharmacology & Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, USA

    7 shared publications
  • Ping-Jin Gao

    Department of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200025, PR China; Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200025, PR China

    6 shared publications
  • Ping-Jin Gao

    Shanghai Key Laboratory of Vascular Biology at Ruijin Hospital and Shanghai Institute of Hypertension, Shanghai Jiaotong University School of Medicine, Shanghai, China

    6 shared publications
  • Ding-Liang Zhu

    5 shared publications
  • Krishna M. Boini

    Department of Pharmacology & Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, USA

    5 shared publications

Latest Publications

  • Open Access

    Identification of Plasma Proteins Mediating the Impact of Osteoarthritis on Ulcerative Colitis

    by Lian Xu, Lin-Xi Yu, Tian-Yu Zhu, Pingjin Gao, Wei-Qing Han

    Background and Aims: This study examined whether osteoarthritis (OA) could causally lead to gastrointestinal disease (GID) risk including Crohn's disease (CD), ulcerative colitis (UC), oesophageal ulcer (OU), gastroduodental ulcer (GDU). We further identified plasma proteins that serve as mediators of OA on GID. Methods: We conducted Mendelian randomization analyses to evaluate the causal effects of knee osteoarthritis (KneeOA), hip osteoarthritis (HipOA), total knee replacement (TKR), total hip replacement (THR), spine osteoarthritis (SpineOA), finger OA (FigureOA), and thumb OA (ThumbOA) on GID outcomes with genome-wide association study (GWAS) data of UK Biobank, FinnGen Consortium and MSK-KP. We also identified plasma proteins that mediate these effects by using GWAS data from the UK Biobank Pharma Proteomics Project (UKB-PPP). Results: Our study revealed a causal effect of KneeOA and THR on increased risk of UC. In contrast, TKR, HipOA, SpineOA, FingerOA and ThumbOA showed no causal relationships with any of the four types of GID. Of note, we identified 14 proteins that mediate the effect of KneeOA and THR on UC. Among them, 9 plasma proteins that mediate the detrimental effect of KneeOA on UC which are mainly related to inflammation, retinoic acid signaling activation and impaired glucose metabolism, and 3 plasma proteins that mediate the impact of THR on UC were all related to increased inflammation. Conversely, 2 plasma proteins that mediate protective effects of KneeOA on UC are mainly related to decreased inflammation. Conclusions: We identified plasma proteins that mediate the effect of OA on GID risk, and these plasma proteins may serve as potential therapeutic targets for treating gastrointestinal conditions in patients with OA.

  • Open Access

    HIF-1α-BNIP3-mediated mitophagy in tubular cells protects against renal ischemia/reperfusion injury

    by Zong-Jie Fu, Zhi-Yu Wang, Lian Xu, Xiao-Hui Chen, Xiang-Xiao Li, Wei-Tang Liao, Hong-Kun Ma, Meng-Di Jiang, Ting-Ting Xu, Jing Xu, et al.


  • Involvement of Angiotensin II Type 1 Receptor and Calcium Channel in Vascular Remodeling and Endothelial Dysfunction in Rats with Pressure Overload

    by Dong-Rui Chen, Hui Jiang, Jing Chen, Cheng-Chao Ruan, Wei-Qing Han, Ping-Jin Gao

    Summary Vascular remodeling is an adaptive response to various stimuli, including mechanical forces, inflammatory cytokines and hormones. In the present study, we investigated the role of angiotensin II type 1 receptor (AT1R) and calcium channel in carotid artery remodeling in response to increased biomechanical forces by using the transverse aortic constriction (TAC) rat model. TAC was induced on ten-week-old male Sprague-Dawley rats and these models were treated with AT1R blocker olmesartan (1 mg/kg/day) or/and calcium channel blocker (CCB) amlodipine (0.5 mg/kg/day) for 14 days. After the treatment, the right common carotid artery proximal to the band (RCCA-B) was collected for further assay. Results showed that olmesartan, but not amlodipine, significantly prevented TAC-induced adventitial hyperplasia. Similarly, olmesartan, but not amlodipine, signifcantly prevented vascular infammation, as indicated by increased tumor necrosis factor α (TNF-α) and increased p65 phosphorylation, an indicator of nuclear factor κ-light-chain-enhancer of activated B cells (NFκB) activation in RCCA-B. In contrast, both olmesartan and amlodipine reversed the decreased expression of endothelial nitric oxidase synthase (eNOS) and improved endothelium-dependent vasodilation, whereas combination of olmesartan and amlodipine showed no further synergistic protective effects. These results suggest that AT1R was involved in vascular remodeling and inflammation in response to pressure overload, whereas AT1R and subsequent calcium channel were involved in endothelial dysfunction.


  • Membrane raft redox signalling contributes to endothelial dysfunction and vascular remodelling of thoracic aorta in angiotensin II‐infused rats

    by Jian Wei, Lian Xu, Ya‐Nan Du, Xiao‐Feng Tang, Mao‐Qing Ye, Yong‐Jie Wu, Wei‐Qing Han, Ping‐Jin Gao

    New Findings: What is the central question of this study? Is the membrane raft redox signalling pathway involved in blood pressure increase, endothelial dysfunction and vascular remodelling in an angiotensin II‐induced hypertensive animal model? What is the main finding and its importance? The membrane raft redox signalling pathway was involved in endothelial dysfunction and medial remodelling in angiotensin II‐induced hypertension. The membrane raft (MR) redox pathway is characterized by NADPH oxidase activation via the clustering of its subunits through lysosome fusion and the activation of acid sphingomyelinase (ASMase). Our previous study shows that the MR redox signalling pathway is associated with angiontensin II (AngII)‐induced production of reactive oxygen species (ROS) and endothelial dysfunction in rat mesenteric arteries. In the present study, we hypothesized that this signalling pathway is involved in blood pressure increase, endothelial dysfunction and vascular remodelling in an AngII‐induced hypertensive animal model. Sixteen‐week‐old male Sprague–Dawley rats were subjected to AngII infusion for 2 weeks with or without treatment with the lysosome fusion inhibitor bafilomycin A1 and ASMase inhibitor amitriptyline. After treatments, aortas were harvested for further study. The results showed that the MR redox signalling pathway was activated as indicated by the increase of MR formation, ASMase activity and ROS production in aorta from AngII‐infused rats compared with that from control rats. MR formation and ROS production were significantly inhibited in thoracic aorta from AngII‐induced rats treated with bafilomycin A1 and amitriptyline. Both treatments significantly attenuated blood pressure increase, endothelial dysfunction and vascular remodelling including medial hypertrophy, and increased collagen and fibronectin deposition in thoracic aortas from AngII‐infused rats. Finally, both treatments significantly prevented the increase of inflammatory factors including monocyte chemotactic protein 1, intercellular adhesion molecule 1 and tumour necrosis factor α in thoracic aorta from AngII‐infused rats. In conclusion, the present study demonstrates that the MR redox signalling pathway was involved in endothelial dysfunction and medial remodelling in AngII‐induced hypertension.


  • Open Access

    SGK1-FoxO1 Signaling Pathway Mediates Th17/Treg Imbalance and Target Organ Inflammation in Angiotensin II-Induced Hypertension

    by Ya-Nan Du, Xiao-Feng Tang, Lian Xu, Wen-Dong Chen, Ping-Jin Gao, Wei-Qing Han

    It has been demonstrated that serum/glucocorticoid regulated kinase 1 (SGK1) and the downstream transcription factor forkhead box O1 (FoxO1) plays a critical role in the differentiation of T helper 17 cells/regulatory T cells (Th17/Treg). In the present study, we hypothesized that this SGK1-FoxO1 signaling pathway is involved in Th17/Treg imbalance and target organ damage in angiotensin II (AngII)-induced hypertensive mice. Results show that SGK1 inhibitor EMD638683 significantly reversed renal dysfunction and cardiac dysfunction in echocardiography as indicated by decreased blood urine nitrogen and serum creatinine in AngII-infused mice. Flow cytometric assay shows that there was significant Th17/Treg imbalance in spleen and in renal/cardiac infiltrating lymphocytes as indicated by the increased Th17 cells (CD4+-IL17A+ cells) and decreased Treg cells (CD4+-Foxp3+). Consistently, real-time PCR shows that Th17-related cytokines including IL-17A, IL-23, and tumor necrosis factor α (TNF-α) was increased and Treg-related cytokine IL-10 was decreased in renal and cardiac infiltrating lymphocytes in AngII-infused mice. Meanwhile, SGK1 protein level, as well as its phosphorylation and activity, was significantly increased in spleen in AngII-infused rats. Furthermore, it was found that splenic phosphorylated FoxO1 was significantly increased, whereas total FoxO1 in nuclear preparation was significantly decreased in AngII-infused mice, suggesting that increased FoxO1 phosphorylation initiate its translocation from cytoplasm to nucleus. Notably, all changes were significantly inhibited by the treatment of EMD638683. These results suggest that SGK1 was involved in Th17/Treg imbalance and target organ damage in AngII-induced hypertension.


  • Membrane rafts–redox signalling pathway contributes to renal fibrosis via modulation of the renal tubular epithelial–mesenchymal transition

    by Wei‐Qing Han, Lian Xu, Xiao‐Feng Tang, Wen‐Dong Chen, Yong‐Jie Wu, Ping‐Jin Gao

    Key points: Membrane rafts (MRs)–redox signalling pathway is activated in response to transforming growth factor‐β1 (TGF‐β1) stimulation in renal tubular cells. This pathway contributes to TGF‐1β‐induced epithelial–mesenchymal transition (EMT) in renal tubular cells. The the MRs–redox signalling pathway is activated in renal tubular cells isolated from angiotensin II (AngII)‐induced hypertensive rats. Inhibition of this pathway attenuated renal inflammation and fibrosis in AngII‐induced hypertension. The membrane rafts (MRs)–redox pathway is characterized by NADPH oxidase subunit clustering and activation through lysosome fusion, V‐type proton ATPase subunit E2 (encoded by the Atp6v1e2 gene) translocation and sphingomyelin phosphodiesterase 1 (SMPD1, encoded by the SMPD1 gene) activation. In the present study, we hypothesized that the MRs–redox‐derived reactive oxygen species (ROS) are involved in renal inflammation and fibrosis by promoting renal tubular epithelial–mesenchymal transition (EMT). Results show that transforming growth factor‐β1 (TGF‐β1) acutely induced MR formation and ROS production in NRK‐52E cells, a rat renal tubular cell line. In addition, transfection of Atp6v1e2 small hairpin RNAs (shRNA) and SMPD1 shRNA attenuated TGF‐β1‐induced changes in EMT markers, including E‐cadherin, α‐smooth muscle actin (α‐SMA) and fibroblast‐specific protein‐1 (FSP‐1) in NRK‐52E cells. Moreover, Erk1/2 activation may be a downstream regulator of the MRs–redox‐derived ROS, because both shRNAs significantly inhibited TGF‐β1‐induced Erk1/2 phosphorylation. Further in vivo study shows that the renal tubular the MRs–redox signalling pathway was activated in angiotensin II (AngII)‐induced hypertension, as indicated by the increased NADPH oxidase subunit Nox4 fraction in the MR domain, SMPD1 activation and increased ROS content in isolated renal tubular cells. Finally, renal transfection of Atp6v1e2 shRNA and SMPD1 shRNA significantly prevented renal fibrosis and inflammation, as indicated by the decrease of α‐SMA, fibronectin, collagen I, monocyte chemoattractant protein‐1 (MCP‐1), intercellular cell adhesion molecule‐1 (ICAM‐1) and tumour necrosis factor‐α (TNF‐α) in kidneys from AngII‐infused rats. It was concluded that the the MRs–redox signalling pathway is involved in TGF‐β1‐induced renal tubular EMT and renal inflammation/fibrosis in AngII‐induced hypertension.


  • Open Access

    Association of a SNP in SLC35F3 Gene with the Risk of Hypertension in a Chinese Han Population

    by Xiao-Li Zang, Wei-Qing Han, Feng-Ping Yang, Kai-Da Ji, Ji-Guang Wang, Ping-Jin Gao, Guang He, Sheng-Nan Wu

    A recent study suggested that SLC35F3 which encoded a thiamine transporter was a new candidate gene for hypertension. The goal of this study was to investigate the association between the single nucleotide polymorphisms (SNPs) in the SLC35F3 gene and hypertension in a Chinese population. Sanger sequencing was performed in 93 samples to find SNPs in coding regions and intron-exon boundaries in the SLC35F3 gene. We found eight genetic variants in the coding regions of SLC35F3 and subsequently genotyped a non-synonymous variant rs34032258 (C>G) in 1060 hypertension patients and 1467 controls. After adjusting for age and gender, multivariate analysis of covariance showed that the variant was associated with hypertensive traits. In detail, diastolic blood pressure (DBP) was 8 mmHg higher, blood urea nitrogen (BUN) was 12 mmol/L higher, and creatinine (Cr) was 15 mmol/L lower in G/G group compared with C/C group (P =0.007; 0.012 and 0.029 respectively). Further study suggested that C/G+G/G had higher DBP than C/C genotype in those whose DBP ≥ 90 mmHg (98.02 mmHg vs. 94.04 mmHg, P=0.021). No significant difference has been found in systolic blood pressure (SBP) between different genotypes. Additionally, in the subgroup of obesity, allele distribution of this variant has shown significant difference between hypertensive patients and normotensive controls (P=0.018). In conclusion, we found that the rs34032258 in the SLC35F3 gene was associated with high blood pressure and may increase the risk of hypertension. The new hypertension-susceptibility locus may involve in the pathogenesis of hypertension and indicate some novel treatment implications.


  • Protease-activated receptor 1 and 2 contribute to angiotensin II-induced activation of adventitial fibroblasts from rat aorta

    by Rui-Qing He, Xiao-Feng Tang, Bao-Li Zhang, Xiao-Dong Li, Mo-Na Hong, Qi-Zhi Chen, Wei-Qing Han, Ping-Jin Gao


  • Ca2+-regulated lysosome fusion mediates angiotensin II-induced lipid raft clustering in mesenteric endothelial cells

    by Wei-Qing Han, Wen-Dong Chen, Ke Zhang, Jian-Jun Liu, Yong-Jie Wu, Ping-Jin Gao

    Hypertension Research, official publication of the Japanese Society of Hypertension, publishes papers reporting original clinical and experimental research in the field of hypertension and related cardiovascular diseases.